Relationships Between Hourly Cognitive Variability and Risk of Alzheimer's Disease Revealed With Mixed-Effects Location Scale Models

被引:6
|
作者
Aschenbrenner, Andrew J. [1 ,4 ]
Hassenstab, Jason [1 ,2 ]
Morris, John C. [1 ]
Cruchaga, Carlos [3 ]
Jackson, Joshua J. [2 ]
机构
[1] Washington Univ, Sch Med, Dept Neurol, St Louis, MO USA
[2] Washington Univ, Dept Psychol & Brain Sci, St Louis, MO USA
[3] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO USA
[4] Washington Univ, Sch Med, Dept Neurol, 4488 Forest Pk Ave,Suite 301, St Louis, MO 63108 USA
关键词
Alzheimer's disease; variability; cognition; measurement burst; apolipoprotein E; REACTION-TIME PERFORMANCE; INTRAINDIVIDUAL VARIABILITY; OLDER-ADULTS; APOLIPOPROTEIN-E; MEMORY; DEMENTIA; DISTRIBUTIONS; BIOMARKERS; COMPONENTS; WORKING;
D O I
10.1037/neu0000905
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objective: Observational studies on aging and Alzheimer's disease (AD) typically focus on mean-level changes in cognitive performance over relatively long periods of time (years or decades). Additionally, some studies have examined how trial-level fluctuations in speeded reaction time are related to both age and AD. The aim of the current project was to describe patterns of variability across repeated days of testing as a function of AD risk in cognitively normal older adults. Method: The current project examined the performance of the Ambulatory Research in Cognition (ARC) smartphone application, a high-frequency remote cognitive assessment paradigm, that administers brief tests of episodic memory, spatial working memory, and processing speed. Bayesian mixed-effects location scale models were used to explore differences in mean cognitive performance and intraindividual variability across 28 repeated sessions over a 1-week assessment interval as function of age and genetic risk of AD, specifically the presence of at least one apolipoprotein E (APOE) e4 allele. Results: Mean performance on processing speed and working memory was negatively related to age and APOE status. More importantly, e4 carriers exhibited increased session-level variability on a test of processing speed compared to noncarriers. Age and education did not consistently relate to cognitive variability, contrary to expectations. Conclusion: Preclinical AD risk, defined as possessing at least one APOE e4 allele, is not only associated with mean-level performance differences, but also with increases in variability across repeated testing occasions particularly on a test of processing speed. Thus, cognitive variability may serve as an additional and important indicator of AD risk.
引用
收藏
页码:69 / 80
页数:12
相关论文
共 50 条
  • [21] Patterns of cognitive performance on the Alzheimer's disease assessment scale-cognition differentiate between Alzheimer's disease and vascular dementia
    Posner, H
    Selnes, O
    Stern, Y
    Ferris, SH
    Shaikh, R
    Schindler, RJ
    [J]. NEUROLOGY, 2006, 66 (05) : A345 - A345
  • [22] Linear and Nonlinear Relationships Between Cognitive Subdomains of Ability Discrepancy and Alzheimer's Disease Biomarkers
    McDonough, Ian M.
    Popp, Taylor E.
    [J]. NEUROPSYCHOLOGY, 2020, 34 (02) : 211 - 226
  • [23] Relationships between hippocampal shape and cognitive performances in the drug naive patients with Alzheimer's disease
    Lim, Hyun Kook
    Won, Wang Yeun
    Hahn, Changtae
    Lee, Chang Uk
    [J]. ASIA-PACIFIC PSYCHIATRY, 2012, 4 : 136 - 136
  • [24] Relationships Between Plasma Lipids Species, Gender, Risk Factors, and Alzheimer's Disease
    Lim, Wei Ling Florence
    Huynh, Kevin
    Chatterjee, Pratishtha
    Martins, Ian
    Jayawardana, Kaushala S.
    Giles, Corey
    Mellett, Natalie A.
    Laws, Simon M.
    Bush, Ashley I.
    Rowe, Christopher C.
    Villemagne, Victor L.
    Ames, David
    Drew, Brian G.
    Masters, Colin L.
    Meikle, Peter J.
    Martins, Ralph N.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2020, 76 (01) : 303 - 315
  • [25] Relationships between optic nerve damage and the severity of cognitive impairment in patients with mild cognitive impairment and Alzheimer's disease
    Zhang, Lina
    Xu, Yuming
    Zhu, Yu
    [J]. BIOMEDICAL RESEARCH-INDIA, 2017, 28 (13): : 5708 - 5712
  • [26] Effects of polygenic risk for Alzheimer's disease on rate of cognitive decline in normal aging
    Kauppi, Karolina
    Ronnlund, Michael
    Adolfsson, Annelie Nordin
    Pudas, Sara
    Adolfsson, Rolf
    [J]. TRANSLATIONAL PSYCHIATRY, 2020, 10 (01)
  • [27] Causal effects of circulating cytokine concentrations on risk of Alzheimer?s disease and cognitive function
    Pagoni, Panagiota
    Korologou-Linden, Roxanna S.
    Howe, Laura D.
    Smith, George Davey
    Ben-Shlomo, Yoav
    Stergiakouli, Evie
    Anderson, Emma L.
    [J]. BRAIN BEHAVIOR AND IMMUNITY, 2022, 104 : 54 - 64
  • [28] Effects of polygenic risk for Alzheimer’s disease on rate of cognitive decline in normal aging
    Karolina Kauppi
    Michael Rönnlund
    Annelie Nordin Adolfsson
    Sara Pudas
    Rolf Adolfsson
    [J]. Translational Psychiatry, 10
  • [29] Relationships between hippocampal shape and cognitive performances in drug-naive patients with Alzheimer's disease
    Lim, Hyun Kook
    Jung, Won Sang
    Ahn, Kook Jin
    Won, Wang Youn
    Hahn, Changtae
    Lee, Seung Yup
    Kim, InSeong
    Lee, Chang Uk
    [J]. NEUROSCIENCE LETTERS, 2012, 516 (01) : 124 - 129
  • [30] Relationships Between CETP Genetic Polymorphisms and Alzheimer's Disease Risk: A Meta-Analysis
    Chen, Jing-Jiong
    Li, Yu-Mei
    Zou, Wen-Ying
    Fu, Jian-Liang
    [J]. DNA AND CELL BIOLOGY, 2014, 33 (11) : 807 - 815